1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. VISTAGEN THERAPEUTICS INC
VistaGen Therapeutics Inc
XNAS: VTGN
0.62 -0.03 (-4.62%)
655.2K
XNAS Volume

XNAS 15 May, 2026 4:11 PM (EDT)

Watchlist

Portfolio

Alert

VistaGen Therapeutics Inc - VTGN - stock price prediction, stock price target, analyst ratings from 5 analysts

VistaGen Therapeutics Inc has a share price target of US$ 1, revenue growth forecast of 110.2%, and profit growth estimate of -38.7% for FY26, based on top 5 analyst calls.